3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Hepatocellular
35
Carcinoma, Non-Small-Cell Lung
32
Colorectal Neoplasms
19
Esophageal Squamous Cell Carcinoma
18
Stomach Neoplasms
17
Squamous Cell Carcinoma of Head and Neck
16
Rectal Neoplasms
11
Cholangiocarcinoma
11
Head and Neck Neoplasms
10
Small Cell Lung Carcinoma
9
Lung Neoplasms
9
Esophageal Neoplasms
9
Triple Negative Breast Neoplasms
8
Uterine Cervical Neoplasms
7
Nasopharyngeal Carcinoma
7
Urinary Bladder Neoplasms
6
Recurrence
6
Pancreatic Neoplasms
6
Neoplasms
6
Colonic Neoplasms
6
Melanoma
5
Hodgkin Disease
5
Biliary Tract Neoplasms
4
Adenocarcinoma of Lung
4
Sarcoma
3
Non-Muscle Invasive Bladder Neoplasms
3
Neoplasm Metastasis
3
NSCLC
3
Locally Advanced Rectal Cancer
3
Liver Neoplasms
3
Interventions
Cyclophosphamide
3
fludarabine
2
Radiotherapy
2
Interleukin-2
2
tislelizumab
1
pembrolizumab
1
pazopanib
1
patritumab deruxtecan
1
palbociclib
1
niraparib
1
neotil
1
lenvatinib
1
atezolizumab
1
Yoga
1
X-Rays
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Tiragolumab
1
Surveys and Questionnaires
1
Radiation
1
Positron-Emission Tomography
1
Nivolumab
1
Magnetic Resonance Imaging
1
Lacteol
1
Ipilimumab
1
High-Throughput Nucleotide Sequencing
1
Fluorodeoxyglucose F18
1
Data Collection
1
Cryosurgery
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Solid Tumor, Adult
×
tislelizumab
×
Clear all
NCT06032845
2025-02-27
CASTLE-11
Fudan University
Phase 2
Recruiting
25 enrolled